STAT

The Ebola response effort is struggling. Experts say these steps could help

The Ebola containment effort is struggling. Experts say there's a way to right the response.
Health workers carry the coffin containing of an Ebola victim in Butembo, in the Democratic Republic of the Congo. Source: JOHN WESSELS/AFP/Getty Images

With Ebola response teams struggling to contain the outbreak in the Democratic Republic of the Congo, the World Health Organization and its partners can make changes to shore up their effort and try to prevent the crisis from escalating further, according to a handful of experts surveyed by STAT.

The experts are wary of criticizing WHO officials and others trying desperately to stop the virus from spreading. Violence aimed at Ebola response workers and a refusal to cooperate with control measures in some communities has rendered this outbreak, the second largest on record, unlike anything the world of Ebola responders has seen before. There have been repeated attacked on Ebola treatment centers, and on many days response workers have been unable to move about in outbreak hotspots.

At the same time, the experts believe global health officials have opportunities to bolster their efforts.

Here are three.

Good data are key

The foundation

You're reading a preview, sign up to read more.

More from STAT

STAT9 min readPolitics
Elizabeth Warren’s Health Care Evolution Has Earned Her Friends On The Left, But Foes In Her Home State
Warren has shifted from a senator, sympathetic to her home state’s health care interests, to a national political figure with her sights on more sweeping policies.
STAT2 min read
Gilead CEO Daniel O’Day Says Company Is In An ‘Acquisitive Mode’
“People are worried about the cash in our pocket,” Gilead CEO Daniel O’Day said, adding that the company is “in an acquisitive mode.”
STAT5 min read
First CRISPR Treatment For Blood Diseases Shows Early Benefits In Two Patients
The first two patients to receive a CRISPR-based treatment for inherited blood disorders have benefited from the experimental therapy, said the companies developing the therapy.